glutamic acid has been researched along with everolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benet, LZ; Christians, U; Jacobsen, W; Leibfritz, D; Litt, L; Niemann, CU; Serkova, N | 1 |
| Alavi, MS; Bagheri, A; Fanoudi, S; Hosseini, A; Jalili-Nik, M; Sadeghnia, HR | 1 |
2 other study(ies) available for glutamic acid and everolimus
| Article | Year |
|---|---|
Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain.
Topics: Animals; Aspartic Acid; Body Weight; Brain; Cyclosporine; Drug Synergism; Everolimus; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Immunosuppressive Agents; Magnetic Resonance Spectroscopy; Mitochondria; Oxaloacetic Acid; Phosphates; Rats; Rats, Wistar; Sirolimus; Weight Gain | 2001 |
Everolimus attenuates glutamate-induced PC12 cells death.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Everolimus; Glutamic Acid; Mammals; Neuroprotective Agents; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats | 2023 |